According to a report the COVID-19 vaccine participant whose unexpected illness stopped the AstraZeneca tests came down with an inflammatory syndrome known as transverse myelitis.
One person joined the UK trials when they came down with the condition, which affects the spinal cord and is often sparked by viral infections, a source told the New York Times.
FAUCI Apollo Coronavirus Vacancy Projection Timeline
According to the Mayo Clinic, the disease causes inflammation of both sides of the spine, which sends messages throughout the body and potentially causes paralysis.
It is also associated with pain, muscle weakness, sensory problems or bladder and bowel dysfunction.
The drug giant vowed to investigate whether the vaccine, which was developed with the University of Oxford in Britain, was responsible for the syndrome.
Can you see friends and family before getting a coronary test?
“It is a routine action that is examined whenever a potentially unexplained disease occurs in a single trial,” AstraZeneca said in a statement.
“In larger trials, the disease will be coincidental but must be reviewed independently to be carefully examined.”